Your Cart ( 1 Item )

• A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment
  October 2018 | Volume 17 | Issue 10 | Original Article | 1100 | Copyright © October 2018
  Stephen K. Tyring MD PhD,^a Theodore Rosen MD,^b Brian Berman MD PhD,^c Nathan Stasko PhD,^d Todd Durham PhD,^d Tomoko Maeda-Chubachi MD PhD MBA^d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs